Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on April 15, 2025
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction
GlobeNewswire
·
April 15, 2025
WARREN, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced the commission of Databricks, Inc., a leader in data, analytics and artificial intelligence (AI), with an aim to accelerate …
Best Steroids For Muscle Growth, Cutting, Muscle Building Steroids, Is Testosterone a Steroid, Buy Legal Steroids, Steroid to Build Muscle, Purchase Steroids (By CrazyBulk)
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Natural, safe, …
Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight
GlobeNewswire
·
April 15, 2025
New York, USA, April 15, 2025 (GLOBE NEWSWIRE) -- Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight According to DelveInsight’s analysis, the market for GIST …
Best Muscle Growth Steroids, Cutting, Anabolic Steroids For Bodybuilding, Is Steroids Testosterone, Do Bodybuilders Use Steroids, Steroids For Muscles (By CrazyBulk)
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- I have worked with many bodybuilders over 30 years, from professionals to beginners. People often ask me what the most effective steroid is for building huge muscles. The answer is Dianabol (also known as Dbol). …
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory
GlobeNewswire
·
April 15, 2025
KUALA LUMPUR, Malaysia, April 15, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a diversified biotechnology and specialty materials group headquartered in Malaysia and incorporated in Wyoming, today …
A new Truveta study offers a hopeful sign: Syphilis incidence is down for the first time in decades
GlobeNewswire
·
April 15, 2025
BELLEVUE, WA, April 15, 2025 (GLOBE NEWSWIRE) -- A new study published in the American Journal of Preventive Medicine spotlights a pivotal shift in syphilis transmission patterns across the United States, leveraging Truveta Data to deliver the most timely …
AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit
GlobeNewswire
·
April 15, 2025
BERWYN, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces the promotion of Donovan Quill to chief strategy officer, Life Sciences, and …
During Oral Cancer Awareness Month, Benevis Raises Visibility for the Importance of Early Detection Through Routine Dental Care
GlobeNewswire
·
April 15, 2025
Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- During April’s Oral Cancer Awareness Month, Benevis joins its dental industry peers in efforts to highlight the importance of good oral hygiene and proactive risk assessments for the disease. Oral cancer is …
CareSource awarded Nevada Medicaid Managed Care contract
GlobeNewswire
·
April 15, 2025
HENDERSON, Nev., April 15, 2025 (GLOBE NEWSWIRE) -- The Nevada Department of Health and Human Services Division of Health Care Financing and Policy has awarded CareSource, a nationally-recognized, nonprofit managed care organization, a contract for the …
Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets
GlobeNewswire
·
April 15, 2025
ATHENS, Greece and SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Er-Kim Pharmaceuticals, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, today announced it has signed a …
HealthEquity’s Expedited Claims Technology Wins Artificial Intelligence Excellence Awards
GlobeNewswire
·
April 15, 2025
DRAPER, Utah, April 15, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation’s largest Health Savings Account (HSA) administrator, has been recognized by the Business Intelligence Group for its Expedited Claims AI system …
Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems
GlobeNewswire
·
April 15, 2025
RA'ANANA, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- RA'ANANA, Israel, April 15, 2025 -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced …
Ezra Appoints Dr. Danna Chung as Chief Medical Officer
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Ezra, the healthcare AI startup revolutionizing early cancer detection through full-body MRI screening, today announced the appointment of Dr. Danna Chung as Chief Medical Officer and Medical Director. Dr. Chung …
Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without Aura i…
GlobeNewswire
·
April 15, 2025
ELYXYB® is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults.1 According to market data from 2018, it was found that migraine was more severe than other types …
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
GlobeNewswire
·
April 15, 2025
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with relapsed and/or refractory large B-cell lymphoma. RMAT designation recognizes the potential of LYL314 to address significant unmet …
US Remote Patient Monitoring Market worth US$29.13 billion by 2030 with 12.8% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 15, 2025
Delray Beach, FL, April 15, 2025 (GLOBE NEWSWIRE) -- The global US Remote Patient Monitoring Market, valued at US$14.15 billion in 2024, is forecasted to grow at a robust CAGR of 12.8%, reaching US$29.13 billion by 2030. The growing number of elderly …
Confluent Health Honors Physical Therapy Leaders for Service to Patients and Communities
GlobeNewswire
·
April 15, 2025
LOUISVILLE, Ky., April 15, 2025 (GLOBE NEWSWIRE) -- Confluent Health, a nationwide network of physical and occupational therapy companies, recently celebrated local outpatient clinics and clinic directors for demonstrating exceptional leadership, community …
Parexel appoints Charlotte Moser, MD, PhD, MBA as Chief Medical Officer
GlobeNewswire
·
April 15, 2025
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the appointment of Charlotte Moser, MD, PhD …
Sienna Announces April Dividend
GlobeNewswire
·
April 15, 2025
MARKHAM, Ontario, April 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of April 2025, representing $0 …
KFSHRC Treats Artery Blockage with Innovative Non-Surgical Technique
GlobeNewswire
·
April 15, 2025
RIYADH, Saudi Arabia, April 15, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully treated several patients suffering from below-the-knee peripheral artery stenosis and occlusion using an innovative, …